Immunomodulatory Cell Therapy Using αGalCer-Pulsed Dendritic Cells Ameliorates Heart Failure in a Murine Dilated Cardiomyopathy Model.
Masataka IkedaTomomi IdeShouji MatsushimaSoichiro IkedaKosuke OkabeAkihito IshikitaTomonori TadokoroMasashi SadaKo AbeMidori SatoAkiko HanadaShinobu AraiKisho OhtaniAtsushi NonamiShinichi MizunoSachio MorimotoShinichiro MotohashiKoichi AkashiMasaru TaniguchiHiroyuki TsutsuiPublished in: Circulation. Heart failure (2022)
Immunomodulatory cell therapy with αGCDCs is a novel therapeutic strategy for heart failure in DCM.